Rocket Lab’s (RKLB) “Buy” Rating Reaffirmed at TD Cowen

Rocket Lab (NASDAQ:RKLB)‘s stock had its “buy” rating reissued by TD Cowen in a research report issued to clients and investors on Thursday, Benzinga reports. They presently have a $90.00 target price on the rocket manufacturer’s stock. TD Cowen’s price target indicates a potential upside of 70.25% from the company’s current price.

A number of other brokerages have also commented on RKLB. Roth Capital reaffirmed a “buy” rating on shares of Rocket Lab in a research report on Thursday. Wall Street Zen lowered Rocket Lab from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rocket Lab in a research report on Friday, July 17th. Citizens Jmp reaffirmed a “market outperform” rating and issued a $130.00 target price on shares of Rocket Lab in a research report on Tuesday, August 11th. Finally, KeyCorp decreased their target price on Rocket Lab from $135.00 to $100.00 and set an “overweight” rating for the company in a research report on Thursday. Four research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $104.05.

Rocket Lab Trading Down 10.7%

Shares of RKLB stock traded down $6.32 during mid-day trading on Thursday, hitting $52.86. The company’s stock had a trading volume of 27,201,828 shares, compared to its average volume of 22,970,264. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.98 and a current ratio of 5.48. The company’s fifty day simple moving average is $69.91 and its 200-day simple moving average is $84.33. The company has a market cap of $31.63 billion, a PE ratio of -195.75 and a beta of 2.93. Rocket Lab has a 52 week low of $37.57 and a 52 week high of $151.00.

Rocket Lab (NASDAQ:RKLB) last issued its earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The firm had revenue of $234.07 million during the quarter, compared to the consensus estimate of $231.62 million. As a group, equities research analysts expect that Rocket Lab will post -0.20 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Frank Klein sold 35,558 shares of the company’s stock in a transaction that occurred on Thursday, August 27th. The stock was sold at an average price of $66.61, for a total value of $2,368,518.38. Following the completion of the transaction, the insider directly owned 925,737 shares of the company’s stock, valued at $61,663,341.57. This represents a 3.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Arjun Kampani sold 6,034 shares of the company’s stock in a transaction that occurred on Thursday, August 27th. The shares were sold at an average price of $66.65, for a total value of $402,166.10. Following the completion of the transaction, the senior vice president directly owned 250,917 shares of the company’s stock, valued at approximately $16,723,618.05. This represents a 2.35% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 400,749 shares of company stock worth $26,964,474. Company insiders own 8.40% of the company’s stock.

Hedge Funds Weigh In On Rocket Lab

Several institutional investors have recently modified their holdings of the business. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in shares of Rocket Lab in the third quarter valued at approximately $446,000. HBW Advisory Services LLC grew its holdings in shares of Rocket Lab by 2.4% in the third quarter. HBW Advisory Services LLC now owns 7,816 shares of the rocket manufacturer’s stock valued at $545,000 after acquiring an additional 182 shares in the last quarter. Tempus Wealth Planning LLC grew its holdings in shares of Rocket Lab by 3.0% in the third quarter. Tempus Wealth Planning LLC now owns 26,402 shares of the rocket manufacturer’s stock valued at $1,840,000 after acquiring an additional 768 shares in the last quarter. Sanders Morris Harris LLC grew its holdings in shares of Rocket Lab by 7.1% in the third quarter. Sanders Morris Harris LLC now owns 47,078 shares of the rocket manufacturer’s stock valued at $3,479,000 after acquiring an additional 3,138 shares in the last quarter. Finally, Lodestone Wealth Management LLC grew its holdings in shares of Rocket Lab by 17.5% in the third quarter. Lodestone Wealth Management LLC now owns 4,627 shares of the rocket manufacturer’s stock valued at $322,000 after acquiring an additional 688 shares in the last quarter. 71.78% of the stock is owned by institutional investors.

Trending Headlines about Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: TD Cowen reaffirmed its Buy rating with a $90 price target, while Roth Capital maintained a Buy rating with a $110 target. Analysts argue that prioritizing reliability and correcting the manufacturing issue could support Neutron’s long-term prospects. Roth Capital Neutron analysis
• Positive Sentiment: Rocket Lab continues to benefit from strong demand for launch and space systems, including its Electron and HASTE programs. Recent financial information cited approximately $234 million in second-quarter revenue, up about 62% year over year, alongside a substantial backlog and expanding government and defense activity.
• Neutral Sentiment: Cantor Fitzgerald retained a mixed rating but set a $122 price target, suggesting significant longer-term upside if Rocket Lab executes. KeyBanc also advised investors not to panic, though these targets depend heavily on successful Neutron development. Analyst view on Rocket Lab
• Negative Sentiment: Rocket Lab moved Neutron’s maiden flight from the fourth quarter of 2026 to 2027 after identifying manufacturing problems in a forward propellant dome on the first-stage tank. The delay extends the timeline for revenue generation, increases development and cash-burn concerns, and raises questions about program execution. Reuters Neutron launch delay report
• Negative Sentiment: Investors are also weighing recent equity issuance related to the planned Iridium acquisition, lower projected gross margins, and reported insider selling. These factors add dilution and financing overhang to an already volatile, unprofitable stock.

Rocket Lab Company Profile

Rocket Lab USA, Inc is a space and launch company that provides launch services, spacecraft, satellite components and other space systems for commercial, civil and national-security customers. The company designs and manufactures many of its products in-house, supporting missions from initial spacecraft development through launch and on-orbit operations.

Rocket Lab’s primary launch vehicle is Electron, a small-lift rocket designed to place satellites into low Earth orbit. The company also operates the HASTE suborbital test platform for hypersonic and other advanced aerospace technologies and is developing Neutron, a larger reusable rocket intended to serve commercial and government missions.